Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

NORETHINDRONE AND E

Active
SPE2DP-26-T-4362Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the procurement of 1 mg norethindrone and 0.035 mg ethinyl estradiol tablets in a 28-tablet cycle format, with six cycles per package totaling 168 tablets per unit, designated as a single package unit of issue. The product must comply with stringent technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, including adherence to the Medical Marking Standard No. 1 dated February 4, 2013, which supersedes MIL-STD-129. Shelf life is strictly limited to 36 months with no extensions permitted, and storage must be maintained at 20–25°C (68–77°F) as per USP controlled room temperature standards. Labeling must include the NSN, manufacturer, CAGE code, date of manufacture, expiration date, contract number, and lot number. Packaging must be commercial-grade, sealed to prevent damage or breakage, and shipped in suitable exterior containers to ensure safe, cost-effective delivery to the destination point under FOB destination terms. The item is manufactured by Teva Pharmaceuticals USA, Inc., with NDC 00555-9010-58, and is identified by NSN 6505-01-365-2363. Delivery is required within 20 days, with zero tolerance for variance in quantity, and inspection and acceptance occur at the destination. The solicitation is issued under contract number SPE2DP-26-T-4362, with a response deadline of August 4, 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Timothy McCauley listed as the primary point of contact.

General Info

1 mg norethindrone and 0.035 mg ethinyl estradiol tablets, 168 tablets per package, 36-month shelf life, FOB destination, Teva Pharmaceuticals, NSN 6505-01-365-2363.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

6090 STRATHMORE ROAD, RICHMOND, VA, 23237-0000, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Timothy Mccauley
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
NORETHINDRONE AND E
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 MG NORETHINDRONE & 0.035 MG ETHINYL ESTRADIOL
28 TABLETS/CYCLE, 6 CYCLES/PKG (168'S) DIAL-PAK
. UNIT OF ISSUE "PACKAGE" (6 CYCLES CONTAINING TOTAL OF
168 TABLETS/PKG)
. STORE AT 20-25°C (68-77°F). [SEE USP CONTROLLED ROOM TEMPERATURE. ..
LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD
NO. 1A DATED 4 FEBRUARY 2013.
1 PG = 6 EA
LABELS SHALL INCLUDE: NSN MANUFACTURER AND CAGE DATE OF MANUFACTURE,
EXPIRATION, OR RETEST DATE CONTRACT NUMBER/LOT NUMBER..
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT:
SPE2DP-26-T-4362
SECTION B
https://www.dla.mil/Logistics-Operations/Packaging/
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00555-9010-58
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7015747370 0001 PG 6.000
NSN/MATERIAL:6505013652363
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-365-2363 Quantity: 6 PG Purchase Request: 7015747370QTY: 6 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
Supply of Silver Nitrate Applicators for Military Medical UseThe contract entails the manufacture and supply of sterile, individually packaged silver nitrate applicators compliant with stringent military medical standards, intended for use by U.S. Department of Defense medical personnel. These applicators must meet precise quality and safety requirements to ensure reliable performance in field and clinical settings, with delivery directed to DLA Troop Support facilities at Joint Base Pearl Harbor-Hickam, identified by zip code 96853-5256. The solicitation, categorized as a subcontract under NAICS code 325412, is issued by the Medical Supply Chain Pharm FSA under the Department of Defense and requires responses by August 3, 2026. All products must be packaged individually and meet the regulatory, sterilization, and labeling specifications dictated by military medical procurement guidelines to guarantee compatibility and safety in operational environments.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 4 days
View Details
NAICS: 325412
New
DIBBS
MULTIPLE
Solicitation # SPE2DP-26-T-4366
The contract specifies the procurement of MULTIPLE ELECTROLYTES INJECTION, TYPE 1, USP, in 1000 mL plastic bags, containing 14 units per case, with a pharmaceutical pH of 7.4. The product is manufactured by BAXTER HEALTHCARE CORPORATION under part number 2B2544X and is regulated by the FDA. It must be stored at room temperature, 25°C (77°F), with avoidance of excessive heat, and kept tightly closed in a cool, well-ventilated environment. The item has a non-extendable shelf life of 18 months as governed by RS001 for TYPE I (CODE K) classification and must be marked in accordance with the latest Medical Marking Standard No. 1. Packaging must comply with MIL-STD-2073-1E and the DLA packaging requirements, with latex-free plastic containers. The NSN is 6505014625492, and the unit of issue is PG, with a single unit ordered. Delivery is required within 20 days FOB destination, with zero tolerance for quantity variance and inspection and acceptance occurring at the destination. The solicitation number is SPE2DP-26-T-4366, issued by the Department of Defense’s Medical Supply Chain PHARM FSA with performance at Fort Bragg, North Carolina. Technical and quality requirements referenced under R numbers are governed by the DLA Master List of Technical and Quality Requirements, with revision control tied to the solicitation issue date. The contracting official must submit an EBS referral for FDA-regulated product confirmation, including bidder and manufacturer details. The contract was posted July 29, 2026, with a response deadline of August 4, 2026, under NAICS code 325412 for pharmaceutical preparation manufacturing.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENT
Solicitation # SPE2DP-26-T-4364
The contract specifies the procurement of Zinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, supplied in collapsible tubes of 28.35 grams per unit, designated as a tube (TU). The product must be stored at controlled room temperature not exceeding 30°C (86°F) and has a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging and labeling must strictly comply with MIL-STD-129 and the latest Medical Marking Standard No. 1, with all packaging requirements governed by the DLA Master List of Technical and Quality Requirements, which override ASTM D3951. The item is regulated by the FDA, requiring buyer referral for confirmation, and must be shipped via traceable means, excluding parcel post. All shipments are FOB destination with no quantity variance allowed, and inspection and acceptance occur at the delivery point. The item is identified by NSN 6505001501990 and manufacturer part number NDC67777-0223-11 from Dynarex Corp. Deliveries are split across six CLINs totaling 30 tubes, with delivery dates ranging from July 15 to July 30, 2026, directed to various military and government installations across the United States. Each delivery location has specific freight and marking instructions, including traceable carrier details and contract identifiers, and all must adhere to DLA packaging and palletization standards under RP001. The contract number is SPE2DP-26-T-4364 and the unit price is $3.00 per tube for all line items.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
BENZONATATE CAPSULES
Solicitation # SPE2DP-26-T-4357
BENZONATATE CAPSULES, USP, 100 MG, are supplied in bottles of 100 capsules each, with the active ingredient being 100 milligrams of benzonatate per capsule. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) and protected from light, moisture, and humidity. This item falls under a Type I (Code Q) shelf-life classification with a non-extendable shelf life of 36 months and must be marked in accordance with the latest edition of Medical Marking Standard No. 1. It is regulated by the FDA, and buyers are required to submit a referral via EBS to the product specialist, including bidder and manufacturer details such as names, part numbers, and NDC codes. The item is subject to DLA packaging requirements and technical quality standards referenced in the DLA Master List of Technical and Quality Requirements. The contract specifies delivery of four bottles under purchase request 7017663196, with delivery due within 20 days FOB destination, no variance allowed in quantity, and inspection and acceptance occurring at the destination. The NSN is 6505-00-660-1798, and the solicitation number is SPE2DP-26-T-4357, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with a response deadline of August 4, 2026. Primary point of contact is Imerah Burnett, and packaging must comply with MIL-STD-2073-1E.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
TRICHLOROACETIC ACID
Solicitation # SPE2DP-26-T-4354
The contract specifies the procurement of Trichloroacetic Acid, ACS grade, 80% concentration, in 15 mL units, identified by NSN 6505-01-363-7674 and part number 749887 from AmerisourceBergen Drug Corp. The item is classified as a TYPE I (CODE M) with a non-extendable shelf life of 24 months and must be packaged and marked in full compliance with Medical Marking Standard No. 1, superseding MIL-STD-129. Packaging must meet commercial standards with sealed unit containers and shipping containers capable of preventing damage during transit, ensuring safe delivery by common carrier at the lowest cost to the designated destination in APO, 09094-3219. The item is regulated by the FDA, requiring referral through EBS for confirmation, and delivery must occur within 20 days FOB destination with zero quantity variance allowed. Inspection and acceptance occur at the delivery point. Suppliers must provide Safety Data Sheets (SDS) and labels compliant with OSHA’s revised Hazard Communication Standard (29 C.F.R. 1910.1200), effective June 1, 2015, and must train employees on these requirements. All documentation must align with DLA’s Master List of Technical and Quality Requirements, and the unit of issue is BT, equivalent to 15 mL. The contract is issued under SPE2DP-26-T-4354, with a response deadline of August 4, 2026, and is governed by federal procurement regulations including DLA packaging and hazardous material handling standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENT
Solicitation # SPE2DP-26-T-4358
Dibucaine Ointment USP is a topical pharmaceutical product containing one percent dibucaine as the active ingredient, specifically formulated for rectal administration and external use only. It is supplied in a collapsible tube and a rectal applicator, with each unit of issue being a single package containing one ounce or 28 grams of the ointment. Storage requirements mandate a temperature range of 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is regulated by the FDA and must be marked in accordance with the latest edition of Medical Marking Standard No. 1, with a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging must comply with MIL-STD-2073-1E, and government identification must be removed from any non-accepted supplies. The contract specifies a procurement quantity of two packages, to be delivered FOB destination within 20 days, with zero variance allowed in quantity. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, supplied by The Harvard Drug Group, L.L.C. The solicitation number is SPE2DP-26-T-4358, with a response deadline of August 4, 2026, and the place of performance is Nellis AFB, NV. The contract includes adherence to DLA’s Master List of Technical and Quality Requirements, and buyers must submit referrals in EBS to confirm product compliance prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ALBUTEROL SULFATE INHA
Solicitation # SPE2DP-26-T-4353
Albuterol Sulfate Inhalation Aerosol with HFA is a prescription-only medication for oral inhalation, delivering 108 micrograms of albuterol sulfate per actuation, equivalent to 90 micrograms of albuterol base, supplied in an 8.5-gram canister containing 200 metered doses. The product must be stored at room temperature between 59°F and 77°F (15°C and 25°C), protected from extreme heat or cold, with specific warnings against puncturing, exposing to temperatures above 120°F, or spraying into the eyes. It has a non-extendable shelf life of 24 months and is classified as a TYPE I (CODE M) item under the Federal supply system. Labeling must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number, in compliance with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, with each unit sealed in a protective container and shipped in suitable exterior packaging to ensure safe delivery via common carrier. The product is regulated by the FDA and subject to Hazard Communication Standard requirements, mandating submission of Safety Data Sheets and compliant HCS labels aligned with 29 C.F.R. 1910.1200 prior to award, along with employee training on updated chemical labeling protocols. The contract specifies delivery of three units FOB destination within 20 days, with no variance allowed in quantity, and inspection and acceptance occurring at the delivery point. The NSN is 6505-01-543-6562, and the solicitation details identify Teva Pharmaceuticals USA, Inc. and Perrigo Direct Inc. as potential suppliers under procurement number SPE2DP-26-T-4353.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
VECURONIUM BROMIDE FOR
Solicitation # SPE2DP-26-T-4359
Vecuronium Bromide for Injection is a freeze-dried powder containing 10 mg of the active ingredient, supplied in packages of ten vials each, with a total shelf life of 24 months. At the time of receipt by the first government activity, the product must have a minimum of 21 months of remaining shelf life. The powder must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, with containers retained in their outer cartons until use. Packaging and labeling must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed and packaged in commercial shipping containers that ensure safe delivery via common carrier at the lowest rate. The product is not considered hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951, though DLA’s Master List of Technical and Quality Requirements takes precedence. Shipments must be sent by traceable means only; parcel post is prohibited. Deliveries are FOB destination with zero variance allowed, and inspection and acceptance occur upon arrival. The supplier is Hikma Pharmaceuticals USA Inc., with NDC 00143-9234-10, and the contract requires multiple deliveries across different locations and dates in July 2026, totaling eight line items for one or three packages per delivery. All packaging, palletization, and labeling must adhere to DLA Packaging Requirements for Procurement and specific storage and handling instructions.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
PETROLATUM, WHITE
Solicitation # SPE2DP-26-T-4355
The contract specifies the procurement of 8 units (TU) of white petrolatum, USP, with each TU equaling 28 milligrams, for a total quantity of 224 milligrams. The material must comply with stringent packaging and marking requirements per the Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and must be packaged in sealed commercial unit containers that protect against damage, with exterior shipping containers ensuring safe, cost-effective delivery to the destination. The item is classified as a TYPE I (CODE Q) with a non-extendable shelf life of 36 months and must be shipped by the fastest traceable means, excluding parcel post. Delivery is required within five days of award under FOB destination terms with zero quantity variance permitted and acceptance occurring at the delivery point. The product must be commercially packaged per ASTM D3951 unless deemed hazardous under FED-STD-313, in which case TQ requirement IP025 applies; however, all DLA Master List of Technical and Quality Requirements override any conflicting standards. Packaging and labeling must reflect the specified unit of issue and quantity per unit pack, and palletization must adhere to DLA packaging guidelines. The delivery address is for the 0182 IN BN 01 HHC INFANTRY BN in Melrose, MA, with the required delivery date set for July 30, 2026, and the contract reference number is SPE2DP-26-T-4355.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
TYPHOID VI POLYSACCHAR
Solicitation # SPE2DP-26-T-4363
The contract specifies the procurement of Typhoid Vi Polysaccharide Vaccine, a modified acellular vaccine supplied in 10 mL vials, with a total quantity of 10 vials, each containing 20 doses. The vaccine must adhere to the Medical Procurement Item Description (MPID) No. 3 dated 20 March 2006, with modifications including the substitution of “vial” for “box” in packaging references. The product must have a minimum shelf life of 18 months, with at least 15 months remaining at the time of delivery to the first government activity, and this shelf-life requirement is non-extendable. The vaccine requires constant refrigeration between 2 and 8 degrees Celsius (36 to 46 degrees Fahrenheit) throughout transport and storage, and all packaging, labeling, and marking must comply with the latest edition of the Medical Marking Standard No. 1 and MIL-STD-129. Commercial packaging must conform to ASTM D3951 unless overridden by DLA’s Master List of Technical and Quality Requirements, which take precedence. The product is to be delivered FOB destination within five days of the contract award, with no variance allowed in quantity. Delivery is directed to USS RALPH JOHNSON DDG 114 at FPO AP 96691-3300, with transportation governed by DLAD procedure notes C19 and C20. The contract is tied to NSN 6505-01-385-6328 and solicitation SPE2DP-26-T-4363, with an original required delivery date of 31 July 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
SUMATRIPTAN SUCCINA
Solicitation # SPE2DP-26-T-4365
Sumatriptan succinate tablets, 25 mg film-coated, are provided in bottles of nine tablets for the acute treatment of migraine with or without aura in adults and must be stored at controlled room temperature between 20 to 25 °C (68 to 77 °F) with protection from light. The contract specifies adherence to strict packaging and marking standards including MIL-STD-2073-1E and MIL-STD-129, with palletization following DLA packaging requirements and shelf life constrained to 24 months under Type I (Code M) non-extendable limits. Deliveries are scheduled for multiple military installations across Fort Bliss, Fort Hood, and Fort Bragg with firm delivery windows of 20 days and no variance allowed in quantity. Each shipment must be transported via traceable means excluding parcel post, with inspection and acceptance occurring at the destination. The contract includes multiple line items under solicitation SPE2DP-26-T-4365, totaling 54 units (nine-tablet bottles), with delivery dates ranging from April to July 2026, and all items carry the same NSN 6505017246289. The supplier must comply with technical and quality requirements referenced from the DLA Master List, and all labeling and documentation must conform to the Medical Marking Standard No. 1 and government-specific identifiers. Contract performance is tracked through detailed logistics codes, tracking numbers, and government-specific identifiers for procurement, distribution, and accountability.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
Hazardous Material Medical Supply DeliveryThe contract involves the supply and delivery of an FDA-regulated medical product classified as hazardous material, requiring strict adherence to compliant packaging, labeling standards, and the submission of a current Safety Data Sheet. The product has a 24-month shelf life and must be delivered FOB destination within five days of shipment to ensure viability and regulatory compliance. All logistics must align with hazardous material transportation regulations while maintaining the integrity of the medical product throughout transit. The delivery destination is specified as Fort Bragg, North Carolina, with a zip code of 28310, and the contracting entity is the Department of Defense under the Medical Supply Chain Pharm FSA. The NAICS code 325412 indicates the industry classification as pharmaceutical and biological product manufacturing, emphasizing the specialized nature of the product. The solicitation was posted on July 28, 2026, with responses due by August 3, 2026, and is structured as a subcontract opportunity through the DIBBS system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 4 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 541512
New
DIBBS
WAWF Invoice and Receiving Report ProcessingThe contract requires the electronic submission of payment requests and receiving reports through the WAWF system, adhering strictly to DFARS and DLA guidelines for every delivery made under this agreement. All documentation must be accurately and timely processed within the designated system to ensure compliance with federal defense contracting standards. The performance location is specified as JBPHH with a zip code of 96853-5256, and the work falls under the NAICS code 541512, indicating IT consulting services related to defense logistics support. This is a subcontract issued by the Department of Defense’s Medical Supply Chain PHFSA, with a response deadline of August 3, 2026, and a posting date of July 29, 2026. The contract does not include a solicitation number and has no set-aside classification specified. The successful bidder must ensure full alignment with DLA’s procedural requirements and must operate within the specified electronic reporting framework without exception. All activities must support the efficient and compliant flow of supply chain data for medical logistics within the Department of Defense infrastructure.
Computer Systems Design Services

POSTED

about 20 hours ago

DEADLINE

in 4 days
View Details
NAICS: 483111
New
DIBBS
Defense-Compliant Logistics and Ocean Transportation ServicesThe contract is for domestic and international freight management with strict compliance to the Cargo Preference Act, requiring all ocean shipments to be transported on U.S.-flag vessels. Timely submission of ocean bills of lading is mandatory to ensure regulatory adherence and operational continuity. The work is to be performed at Joint Base Pearl Harbor-Hickam, Hawaii, with a response deadline of August 3, 2026, and the solicitation was posted on July 29, 2026. This subcontract is classified under NAICS code 483111, which pertains to ocean freight transportation, and is issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The requirement emphasizes compliance with federal cargo preference laws and logistical precision for defense-related supply chains.
Deep Sea Freight Transportation

POSTED

about 20 hours ago

DEADLINE

in 4 days
View Details
NAICS: 323110
New
DIBBS
Military-Compliant Packaging and Labeling for Medical SuppliesThe contract requires the preservation, unit sealing, and labeling of medical supplies to meet the stringent standards of MIL-STD-2073-1E and Medical Marketing Standard No. 1, ensuring full compliance with U.S. military distribution requirements. All work must be performed in accordance with these specifications to guarantee the integrity, sterility, and readiness of medical materials during transport and storage under demanding operational conditions. The packaging and labeling must support traceability, durability, and compatibility with military logistics systems throughout the supply chain. The solicitation is classified as a subcontract under NAICS code 323110, with a response deadline of August 3, 2026, and a posted date of July 29, 2026. Performance is required at Joint Base Pearl Harbor-Hickam, with the ZIP code 96853-5256. The contracting activity falls under the Department of Defense, specifically the Medical Supply Chain Pharm FSA, and the work must align with the military’s standards for operational readiness and compliance. The contract is open for submission via the DIBBS platform under reference number SPE2DP26Q0124, and bidders must ensure all technical and procedural requirements are fully addressed to be considered.
Commercial Lithographic Printing

POSTED

about 20 hours ago

DEADLINE

in 4 days
View Details
NAICS: 325411
New
DIBBS
NIRMATRELVIR AND RI
Solicitation # SPE2DP-26-T-4361
The contract specifies the procurement of PAXLOVID, a combination antiviral medication containing nirmatrelvir and ritonavir, supplied in blister cards with each card containing two 150 mg nirmatrelvir tablets and one 100 mg ritonavir tablet, representing a single daily dose. Each box contains ten blister cards, providing a full five-day treatment course with two doses per day. The product is manufactured by Pfizer Inc under part number NDC00069-5321-30 and is regulated by the FDA. The item has a fixed shelf life of 36 months, non-extendable, and must be packaged in compliance with DLA standards including MIL-STD-2073-1E and Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must ensure protection from damage and use commercial-grade containers suitable for safe transport at the lowest carrier rate. Each shipment must be palletized per DLA requirements and marked with specific identifiers, and delivery is required FOB destination to the Navy Expeditionary Central Facility in Williamsburg, Virginia. The order quantity is 50 boxes, with a strict 20-day delivery window from the award date, and zero tolerance for quantity variance. Shipment must occur via the fastest traceable means, explicitly excluding parcel post, and must be delivered no later than April 28, 2026. Bidders must specify the manufacturer, part number, and source, and the contracting officer must refer the bid to a product specialist for FDA-regulated product confirmation.
Medicinal and Botanical Manufacturing

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
MORPHINE SULFATE IN
Solicitation # SPE2DP-26-T-4360
Medicinal and Botanical Manufacturing

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
BENZOIN TINCTURE, COMPO
Solicitation # SPE2DP-26-T-4356
Benzoin Tincture, Compound, USP is an over-the-counter topical product intended for external use only, containing 1000 mg of Benzoin Resin per milliliter as the active ingredient and 77 percent alcohol as an inactive ingredient. It is supplied in 16-ounce bottles, equivalent to one pint or 473 milliliters, and is classified as a flammable substance requiring storage between 20°C and 25°C in accordance with USP controlled room temperature standards. The item has a non-extendable shelf life of 36 months, and any delivery to the first government activity must ensure a minimum of 31 months of remaining shelf life at the time of receipt. This product is regulated by the FDA and is subject to hazardous materials requirements, including the mandatory inclusion of a current Material Safety Data Sheet (MSDS) with every shipment and electronic submission to DLA.MSDS@DLA.MIL using the required cover sheet P-75. Packaging must comply with 49 CFR and ICAO regulations for hazardous materials, and all items must be marked in accordance with Medical Marking Standard No. 1, superseding MIL-STD-129. The item is covered under Defense Information potentially applicable provisions and incorporates technical and quality requirements from the DLA Master List. It is identified by NSN 6505-01-654-9628 under solicitation SPE2DP-26-T-4356, with a 20-day delivery deadline and procurement through the Department of Defense’s Medical Supply Chain.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details